Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03625427 · ClinicalTrials.gov registry record · NA
Effect of Palmitoleic Acid on C-reactive Protein
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 123
- Enrollment target
NCT03625427 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 123 participants.
The verdict
NCT03625427, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
Study Summary
This clinical trial will test the effects of an n-7 monounsaturated fatty acid known as palmitoleic acid (POA) on a chronic inflammation marker in overweight subjects. The study will enroll male and female subjects from healthy populations with high levels of the inflammatory marker c-reactive protein (CRP). Investigators will then determine over time if palmitoleic acid supplementation can lower circulating levels of c-reactive protein. Investigators will administer palmitoleic acid at two doses in addition to a placebo and conduct a double-blind parallel arm study. Circulating CRP will be the primary endpoint and secondary endpoints are Interleukin 6 (IL-6), Tumor necrosis factor (TNF) alpha, ghrelin, peptide tyrosine tyrosine (peptide YY), cardio lipid markers, glucose, insulin, leptin, adiponectin, and red blood cell (RBC) and serum fatty acids.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Palmitoleic acid, 500 mg (Dose 1)
- DIETARY_SUPPLEMENT Palmitoleic acid, 1,000 mg (Dose 2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2022-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03625427
The ClinicalTrials.gov registry entry for NCT03625427 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03625427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03625427 about?
NCT03625427 is a clinical study titled "Effect of Palmitoleic Acid on C-reactive Protein". This clinical trial will test the effects of an n-7 monounsaturated fatty acid known as palmitoleic acid (POA) on a chronic inflammation marker in overweight subjects. The study will enroll male and female subjects from healthy populations with high levels of the inflammatory marker c-reactive prote...
What is the current status of trial NCT03625427?
This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2019-09-26. Estimated completion is 2022-11-29.
What interventions are being tested in trial NCT03625427?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Palmitoleic acid, 500 mg (Dose 1) (DIETARY_SUPPLEMENT), Palmitoleic acid, 1,000 mg (Dose 2) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03625427?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.